AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol

• Status: Completed
• Trial end date: 2009-12-01

Summary

Pharmacokinetics and safety of AG200-15 over two consecutive cycles of therapy will be evaluated.

• Phase: Phase 1

Details

• Lead Sponsor: Agile Therapeutics
• Treatments: Contraceptive Agents; Contraceptives, Oral; Estradiol; Ethinyl Estradiol; Ethinyl estradiol, levonorgestrel drug combination; Moxifloxacin; Norgestimate, ethinyl estradiol drug combination